The deal is expected to close in the fourth quarter of this year.
{iframe}https://www.bizjournals.com/washington/news/2019/02/25/danaher-acquires-ge-biopharma-business-for-21-4b.html?u=fQFLvOpMSMnvK7iAcBsVng0eb45ba2&t=1551113639&j=86879321{/iframe}